Corporate News     07-Jan-08
Gufic Biosciences to manufacture oncology products
To commece its operation
Gufic Biosciences has set up manufacturing facility for manufacture of oncology products. The inspection of oncology molecule is completed by FDA and the company is expected to start commercial operation within next two weeks.

The company made this announcement during the trading hours today, 07 January 2008.

Previous News
  Gufic BioSciences standalone net profit rises 10.71% in the March 2024 quarter
 ( Results - Announcements 30-May-24   07:40 )
  Gufic BioSciences standalone net profit declines 32.55% in the June 2022 quarter
 ( Results - Announcements 12-Aug-22   08:15 )
  Gufic Bioscience receives CDSCO nod to manufacture and sale of Antifungal drug
 ( Hot Pursuit - 11-Apr-22   17:45 )
  Gufic BioSciences standalone net profit declines 12.61% in the June 2015 quarter
 ( Results - Announcements 15-Aug-15   15:13 )
  Gufic BioSciences to hold EGM
 ( Corporate News - 14-Aug-20   17:16 )
  Gufic BioSciences reports standalone net loss of Rs 3.75 crore in the June 2020 quarter
 ( Results - Announcements 15-Sep-20   11:27 )
  Gufic BioSciences schedules board meeting
 ( Corporate News - 31-Aug-23   13:42 )
  Gufic BioSciences standalone net profit rises 101.82% in the March 2016 quarter
 ( Results - Announcements 31-May-16   17:20 )
  Gufic BioSciences net profit rises 64.00% in the September 2009 quarter
 ( Results - Announcements 31-Oct-09   19:27 )
  Gufic BioSciences to hold board meeting
 ( Corporate News - 26-May-23   11:11 )
  Gufic Biosciences announces change in directorate
 ( Corporate News - 14-Nov-14   10:40 )
Other Stories
  State Bank of India receives affirmation in credit ratings from Moody's
  03-Oct-24   19:15
  Indian Oil signs B2B Framework Agreement with Nepal Oil Corporation
  03-Oct-24   19:06
  Mahindra & Mahindra's Thar ROXX records 1.76 lakh booking within 60 mins
  03-Oct-24   17:14
  Shilpa Medicare announces receipt of CEP from EDQM for API 'Desmopressin'
  03-Oct-24   17:12
  Board of Refex Industries approves fund raising up to Rs 927 cr via equity route
  03-Oct-24   17:05
  Mahindra & Mahindra Financial Services approves NCD issuance of Rs 750 cr
  03-Oct-24   17:02
  Rites signs MoU with Delhi Metro Rail Corporation
  03-Oct-24   16:42
  Scan Projects to convene board meeting
  03-Oct-24   15:58
  Polycab India to announce Quarterly Result
  03-Oct-24   15:58
  Hindustan Organic Chemicals to conduct board meeting
  03-Oct-24   15:58
Back Top